The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Peroxisomal alterations in Alzheimer’s disease
Open accessAbstract
In Alzheimer's disease (AD), lipid alterations are present early during disease progression. As some of these alterations point towards a peroxisomal dysfunction, we investigated peroxisomes in human postmortem brains obtained from the cohort-based, longitudinal Vienna-Transdanube Aging (VITA) study. Based on the neuropathological Braak staging for AD on one hemisphere, the patients were grouped into three cohorts of increasing severity (stages I-II, III-IV, and V-VI, respectively). Lipid analyses of cortical regions from the other hemisphere revealed accumulation of C22:0 and very long-chain fatty acids (VLCFA, C24:0 and C26:0), all substrates for peroxisomal β-oxidation, in cases with stages V-VI pathology compared with those modestly affected (stages I-II). Conversely, the level of plasmalogens, which need intact peroxisomes for their biosynthesis, was decreased in severely affected tissues, in agreement with a peroxisomal dysfunction. In addition, the peroxisomal volume density was increased in the soma of neurons in gyrus frontalis at advanced AD stages. Confocal laser microscopy demonstrated a loss of peroxisomes in neuronal processes with abnormally phosphorylated tau protein, implicating impaired trafficking as the cause of altered peroxisomal distribution. Besides the original Braak staging, the study design allowed a direct correlation between the biochemical findings and the amount of neurofibrillary tangles (NFT) and neuritic plaques, quantified in adjacent tissue sections. Interestingly, the decrease in plasmalogens and the increase in VLCFA and peroxisomal volume density in neuronal somata all showed a stronger association with NFT than with neuritic plaques. These results indicate substantial peroxisome-related alterations in AD, which may contribute to the progression of AD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“PEX7 regulates peroxisomal protein import, and peroxisomes are abundant in dendrites (Kou et al., 2011).”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Kou et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Kou et al. [127] evidenced heterogeneity in the peroxisomal distribution in neurons of patients with AD, which was concentrated in the soma and absent in the dendrites”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [127]
Experimental — accuracy not yet measuredIn the citing paper
“implying that Tau does not allow the correct transit of these organelles, being an abnormally phosphorylated cytoskeleton protein, the possible cause of the increase in the oxidizing environment.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · cited 1×
“For improved method for analysis of plasmalogen subspecies, lipid standards dissolved in chloroform/methanol (1:2, vol/vol) were added to the extraction solvent before neutral lipid extraction, which was performed according to the method of Bligh and Dyer [5].”
MethodNeuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“The staging of AD-related neuropathology was done on the left brain hemisphere according to Braak and Braak [7, 8].”
BackgroundMethodMitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455 · cited 2×
“Agebased metabolic changes may lead to an imbalance of metabolites and/or second messengers promoting mitochondrial, endosomal–lysosomal and peroxisomal dysfunctions, which might be involved in the initiation of neuropathological events in AD [26, 32].”
BackgroundStrittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 3×
“The staging of AD-related neuropathology was done on the left brain hemisphere according to Braak and Braak [7, 8].”
MethodNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · cited 1×
“Although amyloid b plaques represent a hallmark of AD, NFT pathology is widely considered to correlate better with disease progression [2, 8].”
BackgroundSystematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857 · cited 1×
“So far, the e4 allele of apolipoprotein E (APOE) is the best established genetic risk factor for sporadic AD [4, 39].”
BackgroundExtension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724 · cited 1×
“The observation that the life span of mice is extended when catalase, normally localized to the cytosol and to peroxisomes, is transgenically targeted to mitochondria supports the theory of organellar contribution to aging [37].”
BackgroundConsumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 1×
“DHA incorporated into phospholipids and cholesterol esters were found to be reduced in brain [29] and plasma [12] of AD patients and several studies indicate a decreased risk for AD after an x3 (in particular DHA) rich diet [3, 20, 31].”
Background
Cited by
Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
“This correlates to the observed increase in lipid remodeling, as well as reduced levels of DHA and AA in brain plasmalogen fractions [84,87].”
BackgroundLipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Using Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“PEX7 regulates peroxisomal protein import, and peroxisomes are abundant in dendrites (Kou et al., 2011).”
BackgroundYin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
The peroxisome: an update on mysteries 2.0
Islinger, M., Voelkl, A., Fahimi, H. D., & Schrader, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1722-5 · Cited by 283
Metadata
- Authors
- Kou, J., Kovacs, G. G., Höftberger, R., Kulik, W., Brodde, A., Forss-Petter, S., Hönigschnabl, S., Gleiss, A., Brügger, B., Wanders, R., Just, W., Budka, H., Jungwirth, S., Fischer, P., & Berger, J.
- Affiliations
- Medical University of Vienna (AT)
- Amsterdam UMC Location University of Amsterdam (NL)
- Heidelberg University (DE)
- Ludwig Boltzmann Institute for Age Research (AT)
- Corresponding author
- Berger, Johannes
- ORCID
- Venue
- Acta Neuropathologica
- Published
- 2011-05-19
- Volume
- 122
- Issue
- 3
- Pages
- 271-283
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3168371
- OpenAlex
- W2124956869
- Cited by
- 227
- References
- 42
- Citations by year
- 2026: 7 · 2025: 21 · 2024: 12 · 2023: 20 · 2022: 22 · 2021: 17 · 2020: 25 · 2019: 13 · 2018: 9 · 2017: 12 · 2016: 10 · 2015: 17 · 2014: 19 · 2013: 10 · 2012: 12
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- UvA-DARE (University of Amsterdam) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- European Commission (LSHG-CT-2004-512018)
- Austrian Science Fund (P 21950)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- Alzheimer's disease, peroxisomes, peroxisomal dysfunction, very long chain fatty acids, plasmalogens, peroxisomal beta-oxidation, neurofibrillary tangles, neuritic plaques, Braak staging, tau phosphorylation, neuronal soma
- MeSH terms
- Aged, 80 and over, Alzheimer Disease, Brain, Double-Blind Method, Fatty Acids, Female, Humans, Male, Myelin Sheath, Plasmalogens, Postmortem Changes, Cohort Studies, Neurofibrillary Tangles, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peroxisomal alterations in Alzheimer’s disease. https://app.cochat.ai/papers/10.1007/s00401-011-0836-9
- The paper
- Kou, J., Kovacs, G. G., Höftberger, R., Kulik, W., Brodde, A., Forss-Petter, S., Hönigschnabl, S., Gleiss, A., Brügger, B., Wanders, R., Just, W., Budka, H., Jungwirth, S., Fischer, P., & Berger, J. (2011). Peroxisomal alterations in Alzheimer’s disease. Acta Neuropathologica. https://doi.org/10.1007/s00401-011-0836-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.